Inventor

LEFRANCOIS JEAN-MICHEL

FR21 patents

⚠️ This page may combine multiple inventors who share the name “LEFRANCOIS JEAN-MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEFRANCOIS JEAN-MICHEL

HOECHST AG

Vitronectin receptor antagonists, their preparation and their use

Vitronectin receptor antagonists, their preparation and their use

Vitronectin receptor antagonists, their preparation and their use

Vitronectin receptor anatagonists, their preparation and their use

Vitronectin receptor antagonists, their preparation and their use

Vitronectin receptor antagonists, their preparation and their use

ABBVIE SARL

N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

Compounds for treatment of cystic fibrosis

GALAPAGOS SAS

Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same

Methods for the use of pyrimidine derivatives which are antagonists of vitronectin receptor

Pyrimidine derivatives which are antagonists of vitronectin receptor

Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same

LEFRANCOIS JEAN-MICHEL

Pyrimidine derivatives which are antagonist of the vitronectin receptor

Pyrimidine derivatives which are antagonists of the vitronectin receptor

AVENTIS PHARMA SA

Antagonist derivatives of the vitronectin receptor

HOECHST ATKIENGESELLSCHAFT

Vitronectin receptor antagonists, their preparation and use

ABBVIE S ÀR L

Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use

GALAPAGOS NV

Imidazolidine compounds as androgen receptor modulators

DART THERAPEUTICS LLC

Imidazolidine compounds as androgen receptor modulators